Skip to content
Medicines & Healthcare products Regulatory Agency
The National Institute for Biological Standards and Control

Confidence in biological medicines

  • Stay connected
  • Shopping Basket
  • Pay Now
  • Login / Register
  • Home
  • Products
  • Standardisation
  • Control testing
  • Science and research
  • Expert services
  • About us
  • Latest news
  • Worldwide impact of NIBSC
  • Mission and values
  • Careers
  • Quality and governance
  • Staff profiles
  • Contact us
  • Collaborations
  • Suppliers
  • Scientific Advisory Committee
  • Minutes of the Animal Welfare and Ethical Review Body
  • Our use of animals
  • Privacy notice
  • Home  /  
  • About us  /  
  • Staff profiles  /  
  • Dr Elaine Gray

Dr Elaine Gray

Dr Elaine Gray is a Principal Scientist with over 40 years of experience in control and standardisation of haemostasis and thrombosis related biologicals.  She is responsible for the production of World Health Organisation (WHO) International Standards and British Standards for coagulation factors II, IX, X, XI; plasma coagulation inhibitors such as Antithrombin and protein C and antithrombotics such as unfractionated and low molecular weight heparin. In addition, she works closely with pharmacopoeias, developing written and physical standards.  She is a visiting Professor at the Institute of Pharmaceutical Science, King’s College London.

Her current research interests include measurement issues related to modified and novel therapeutics for treatment of haemophilia and non-anticoagulant properties of heparin and heparin related products.

 

 
Current position

Principal Scientist,  Haemostasis section, Division of Biotherapeutics

Areas of interest

Coagulation factors and inhibitors
Antithrombotics, including:
Unfractionated heparin
Low molecular weight heparins
Direct thrombin and FXa inhibitors

Qualifications

1986: PhD, “Lipoproteins, Blood Coagulation and Thrombosis”, NIBSC/CNAA

1979:
 BSC, Biological Sciences, University of Hertfordshire, 

Recent publications
 (PDF, 45KB)

Representation on external committees

United States Pharmacopoeia (USP) Biologics and Biotechnology  

European Pharmacopoeia (EP) and European Directorate for the Quality of Medicine s and Healthcare (EDQM)

European Medicines Agency (EMA)
United Kingdom National External Quality Assessment Service (UK NEQAS) for Blood Coagulation: Member, Steering Committee

British Committee for Standards in Haematology: Member, Thrombosis and haemostasis Task Force

Joint Committee for Traceability in Laboratory Medicine

Consultative Committee for Amount of Substance (CCQM)

Southern Academic Coagulation Consortium
  • Careers
  • Terms and conditions
  • Accessibility
  • Privacy notice
  • Cookies
  • Sitemap